A detailed history of Deprince Race & Zollo Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Deprince Race & Zollo Inc holds 324,948 shares of JNJ stock, worth $47.4 Million. This represents 1.02% of its overall portfolio holdings.

Number of Shares
324,948
Previous 301,881 7.64%
Holding current value
$47.4 Million
Previous $44.1 Million 19.35%
% of portfolio
1.02%
Previous 1.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$145.48 - $167.38 $3.36 Million - $3.86 Million
23,067 Added 7.64%
324,948 $52.7 Million
Q2 2024

Aug 14, 2024

SELL
$144.38 - $157.78 $533,628 - $583,154
-3,696 Reduced 1.21%
301,881 $44.1 Million
Q1 2024

May 15, 2024

BUY
$155.22 - $162.74 $1.88 Million - $1.98 Million
12,138 Added 4.14%
305,577 $48.3 Million
Q4 2023

Feb 14, 2024

SELL
$145.6 - $158.88 $466,211 - $508,733
-3,202 Reduced 1.08%
293,439 $46 Million
Q3 2023

Nov 14, 2023

SELL
$155.75 - $174.48 $348,257 - $390,137
-2,236 Reduced 0.75%
296,641 $46.2 Million
Q2 2023

Aug 14, 2023

SELL
$154.35 - $166.11 $1.09 Million - $1.18 Million
-7,082 Reduced 2.31%
298,877 $49.5 Million
Q1 2023

May 15, 2023

BUY
$151.05 - $180.26 $4.85 Million - $5.79 Million
32,126 Added 11.73%
305,959 $47.4 Million
Q4 2022

Feb 14, 2023

SELL
$160.2 - $179.79 $5.29 Million - $5.93 Million
-33,006 Reduced 10.76%
273,833 $48.4 Million
Q3 2022

Nov 14, 2022

BUY
$161.33 - $179.52 $9.76 Million - $10.9 Million
60,476 Added 24.55%
306,839 $50.1 Million
Q2 2022

Aug 15, 2022

SELL
$168.19 - $186.01 $121,096 - $133,927
-720 Reduced 0.29%
246,363 $43.7 Million
Q1 2022

May 16, 2022

SELL
$158.14 - $179.59 $85,711 - $97,337
-542 Reduced 0.22%
247,083 $43.8 Million
Q4 2021

Feb 14, 2022

BUY
$155.93 - $173.01 $10.7 Million - $11.9 Million
68,559 Added 38.29%
247,625 $42.4 Million
Q3 2021

Nov 17, 2021

SELL
$161.5 - $179.47 $499,358 - $554,921
-3,092 Reduced 1.7%
179,066 $28.9 Million
Q2 2021

Aug 12, 2021

BUY
$159.48 - $171.07 $351,653 - $377,209
2,205 Added 1.23%
182,158 $30 Million
Q1 2021

May 18, 2021

BUY
$153.07 - $170.48 $8.52 Million - $9.49 Million
55,638 Added 44.76%
179,953 $29.6 Million
Q4 2020

Feb 16, 2021

BUY
$137.11 - $157.38 $2.1 Million - $2.41 Million
15,323 Added 14.06%
124,315 $19.6 Million
Q3 2020

Nov 16, 2020

BUY
$140.38 - $153.83 $290,726 - $318,581
2,071 Added 1.94%
108,992 $16.2 Million
Q2 2020

Aug 11, 2020

SELL
$128.81 - $155.51 $4.47 Million - $5.39 Million
-34,683 Reduced 24.49%
106,921 $15 Million
Q1 2020

Apr 13, 2020

BUY
$111.14 - $153.99 $51,124 - $70,835
460 Added 0.33%
141,604 $18.6 Million
Q4 2019

Feb 14, 2020

SELL
$127.5 - $146.44 $1.62 Million - $1.86 Million
-12,681 Reduced 8.24%
141,144 $20.6 Million
Q3 2019

Nov 14, 2019

BUY
$126.95 - $142.14 $1.16 Million - $1.3 Million
9,146 Added 6.32%
153,825 $19.9 Million
Q2 2019

Aug 13, 2019

BUY
$131.15 - $144.24 $412,204 - $453,346
3,143 Added 2.22%
144,679 $20.2 Million
Q1 2019

Apr 18, 2019

SELL
$125.72 - $139.79 $182,294 - $202,695
-1,450 Reduced 1.01%
141,536 $0
Q4 2018

Jan 30, 2019

SELL
$122.84 - $147.84 $2.47 Million - $2.97 Million
-20,084 Reduced 12.32%
142,986 $18.5 Million
Q3 2018

Oct 15, 2018

SELL
$121.58 - $142.88 $179,938 - $211,462
-1,480 Reduced 0.9%
163,070 $22.5 Million
Q2 2018

Jul 17, 2018

BUY
$119.4 - $131.76 $1.31 Million - $1.45 Million
10,991 Added 7.16%
164,550 $20 Million
Q1 2018

Apr 18, 2018

BUY
$125.1 - $148.14 $1.16 Million - $1.37 Million
9,280 Added 6.43%
153,559 $19.7 Million
Q4 2017

Jan 26, 2018

SELL
$131.22 - $143.62 $1.64 Million - $1.79 Million
-12,484 Reduced 7.96%
144,279 $20.2 Million
Q3 2017

Nov 07, 2017

BUY
$129.47 - $135.38 $20.3 Million - $21.2 Million
156,763
156,763 $20.4 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Deprince Race & Zollo Inc Portfolio

Follow Deprince Race & Zollo Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deprince Race & Zollo Inc, based on Form 13F filings with the SEC.

News

Stay updated on Deprince Race & Zollo Inc with notifications on news.